Litcius/Paper detail

Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade

Robert J. Motzer, Romain Banchereau, Habib Hamidi, Thomas Powles, David F. McDermott, Michael B. Atkins, Bernard Escudier, Lifen Liu, Ning Leng, Alexander R. Abbas, Jinzhen Fan, Hartmut Koeppen, Jennifer Lin, Susheela Carroll, Kenji Hashimoto, Sanjeev Mariathasan, Marjorie Green, Darren Tayama, Priti S. Hegde, Christina Schiff, Mahrukh Huseni, Brian I. Rini

2020Cancer Cell563 citationsDOIOpen Access PDF

Topics & Concepts

AngiogenesisAtezolizumabSunitinibCancer researchCDKN2AImmune checkpointRenal cell carcinomaBevacizumabBlockadeBiologyCancerMedicineNivolumabOncologyInternal medicineImmunotherapyReceptorChemotherapyRenal cell carcinoma treatmentCancer Genomics and DiagnosticsBladder and Urothelial Cancer Treatments
Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade | Litcius